Check-Cap (NSDQ:CHEK) said its X-ray-enabled, colorectal cancer-screening capsule will have a pilot study in the United States. The Isfiya, Israel-based startup makes the C-Scan System, an ingestible capsule used to detect precancerous polyps without the need for laxatives or an invasive procedure. The C-Scan system uses an ultra-low dose X-ray capsule, an integrated positioning, control, and recording system, and proprietary […]
Check-Cap raises $8m
Check-Cap (NSDQ:CHEK) said today that it inked a direct registered offering deal worth approximately $7.5 million to support the continued development of its C-Scan system. The Israel-based company’s C-Scan system is designed as an alternative to standard colon cancer screening methods. The system uses an ingestible, ultra-low dose X-ray capsule and a wireless tracking system to […]
Check-Cap wins conditional IDE approval for C-Scan pilot study
Check-Cap (NSDQ:CHEK) said today it won conditional approval from the FDA for its investigational device exemption application to launch a pilot study of its C-Scan system. The Israel-based company’s C-Scan system is designed as an alternative to standard colon cancer screening methods. The system uses an ingestible, ultra-low dose X-ray capsule and a wireless tracking system […]
Check-Cap touts interim post-CE Mark C-Scan study results
Check-Cap (NSDQ:CHEK) today released interim results from the post-CE Mark approval study of its C-Scan system version 3, touting the device’s ability to detect polyps in un-prepped colons. The Israel-based company’s C-Scan system is designed as an alternative to standard colon cancer screening methods. The system uses an ingestible, ultra-low dose X-ray capsule and a wireless […]
Check-Cap closes $20m Series C
Check-Cap (NSDQ:CHEK) said yesterday it closed an offering of Series C shares and warrants, raising approximately $20.2 million in total. In the offering, the Isfiya, Israel-based company floated approximately 3.2 million units for $5.50 per unit, with each unit in the offering consisting of a single ordinary share or ordinary share equivalent and a Series C […]
Check-Cap prices $18m offering
Check-Cap (NSDQ:CHEK) late last week announced an upcoming offering looking to raise approximately $17.5 million. In the offering, the Isfiya, Israel-based company will look to float approximately 3.2 million units for $5.50 per unit. Each unit in the offering consists of a single ordinary share or ordinary share equivalent and a Series C warrant to purchase one […]
Check-Cap initiates 1-for-12 reverse split
Check-Cap (NSDQ:CHEK) said that earlier this month it initiated a 1-for-12 reverse stock split as it looked to regain compliance with the NASDAQ stock market’s minimum bid pricing requirement. With the move, which was effected on April 4, the Israel-based company put a single share into the hands of every shareholder for each 12 shares they held […]
Tricuspid repair firm 4Tech taps ex-Boston Scientific execs for CEO, CMO | Personnel Moves for Feb. 27, 2018
4Tech said last week that it named a pair of Boston Scientific (NYSE:BSX) veterans as its new CEO and CMO, with onetime chief Mike Ennen stepping away for “family reasons.” Galway, Ireland-based 4Tech said former Boston transcatheter aortic valve GM Tom Fleming is slated to take the reins from Thoratec vet Ennen as president & CEO in […]
Check-Cap wins CE Mark for C-Scan diagnostic capsule
Check-Cap (NSDQ:CHEK) said today it won CE Mark approval in the European Union for its C-Scan ingestible sensor capsule designed for colorectal cancer screening. The Israel-based company’s C-Scan system is designed as an alternative to standard colon cancer screening methods. The system uses an ingestible, ultra-low dose X-ray capsule and a wireless tracking system to return structural […]
Check-Cap seeks CE Mark for C-Scan diagnostic capsule
Check-Cap (NSDQ:CHEK) said today that it filed for CE-Mark registration of its C-Scan ingestible capsule, designed for preparation-free, colorectal cancer screening. Data used to support the EU regulatory submission showed that C-Scan had a 44% sensitivity in the 45 study participants included in an analysis for polyps, with 89% specificity. The company reported that sensitivity strongly […]
Check-Cap closes $3m funding round
Check-Cap (NSDQ:CHEK) said today it closed previously announced definitive agreement with an unnamed healthcare focused institutional investor for $2.7 million. Money in the round came from the sale of 1.4 million shares of stock at $2 per share, the Israel-based company said, with funds slated to support the ongoing development of its C-Scan device. The round also included […]
MassDevice Network
@MassDevice
LinkedIn
YouTube